A detailed history of Exane Derivatives transactions in Stellantis N.V. stock. As of the latest transaction made, Exane Derivatives holds 31,141 shares of STLA stock, worth $426,631. This represents 0.25% of its overall portfolio holdings.

Number of Shares
31,141
Previous 301,766 89.68%
Holding current value
$426,631
Previous $4.91 Million 92.18%
% of portfolio
0.25%
Previous 1.52%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$12.36 - $16.35 $3.34 Million - $4.42 Million
-270,625 Reduced 89.68%
31,141 $384,000
Q1 2022

Apr 22, 2022

SELL
$13.79 - $21.76 $18.8 Million - $29.6 Million
-1,359,929 Reduced 81.84%
301,766 $4.91 Million
Q4 2021

Jan 28, 2022

BUY
$17.13 - $20.5 $16 Million - $19.2 Million
934,941 Added 128.65%
1,661,695 $31.2 Million
Q3 2021

Oct 26, 2021

SELL
$17.85 - $21.82 $12.9 Million - $15.8 Million
-724,649 Reduced 49.93%
726,754 $13.9 Million
Q2 2021

Jul 28, 2021

BUY
$16.57 - $21.26 $8.72 Million - $11.2 Million
526,447 Added 56.92%
1,451,403 $28.6 Million
Q1 2021

Apr 30, 2021

BUY
$15.0 - $18.51 $13.9 Million - $17.1 Million
924,956 New
924,956 $16.5 Million

Others Institutions Holding STLA

About Stellantis N.V.


  • Ticker STLA
  • Exchange NYSE
  • Sector Consumer Cyclical
  • Industry Auto Manufacturers
  • Shares Outstandng 3,213,179,904
  • Market Cap $44B
  • Description
  • Stellantis N.V. engages in the design, engineering, manufacturing, distribution, and sale of automobiles and light commercial vehicles, engines, transmission systems, metallurgical products, and production systems worldwide. It provides luxury, premium, and mainstream passenger vehicles; pickup trucks, sport utility vehicles, and commercial vehi...
More about STLA
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.